The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Delaware Sues Opioid Manufacturers, Distributors Over Epidemic

Delaware Sues Opioid Manufacturers, Distributors Over Epidemic

January 22, 2018 • By Nate Raymond

  • Tweet
  • Email
Print-Friendly Version / Save PDF

(Reuters)—Delaware on Friday became the latest state to file a lawsuit accusing corporations of helping fuel the national opioid epidemic, suing a wide range of companies involved in making, distributing and selling prescription painkillers.1

You Might Also Like
  • Missouri Sues Opioid Manufacturers, Joining Two other U.S. States
  • Kentucky Accuses McKesson of Helping Fuel the Opioid Epidemic
  • New Hampshire Sues Purdue Pharma over Opioid Marketing

The lawsuit, filed by Delaware Attorney General Matt Denn in a state court, targeted drugmakers Purdue Pharma LP and Endo International Plc. along with several wholesale drug distributors and the retailers CVS Health Corp. and Walgreens Boots Alliance Inc. The lawsuit accused Purdue and Endo of engaging in a massive marketing campaign aimed at concealing the risks of using opioids to treat chronic pain in order to overcome a medical consensus that using the drugs for that purpose was unsafe.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Distributors including McKesson Corp, Cardinal Health Inc. and AmerisourceBergen Corp along with the two retailers ignored red flags indicating that opioids were being diverted for illicit uses, according to the lawsuit.

“The failure of these corporate defendants to meet their legal obligations has had a devastating impact on Delawareans,” Denn says in a statement.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Purdue, which produces OxyContin, and Endo, which last year withdrew Opana ER from the market, in separate statements said they denied the allegations, but are concerned about opioid abuse.

AmerisourceBergen says it was dedicated to doing its part to mitigate the diversion of drugs. Cardinal Health said it would defend itself in court.

Other defendants in the lawsuit included Anda, a distributor owned by Teva Pharmaceutical Industries Ltd. Representatives for Anda and the other companies did not immediately respond to requests for comment.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Opioids were involved in over 42,000 overdose deaths in 2016, according to the U.S. Centers for Disease Control and Prevention.

A wave of lawsuits by states, counties and cities have accused drugmakers of pushing addictive painkillers through deceptive marketing and wholesale distributors of failing to report suspicious drug orders.

A group of state attorneys general have been conducting a multistate investigation into whether companies that manufacture and distribute prescription opioids engaged in unlawful practices.

Increasingly, some attorneys general have decided to file lawsuits outside of the probe alone against the companies under scrutiny. At least 14 other states are pursuing opioid-related lawsuits against one or more the companies Delaware sued.

A federal judge in Ohio overseeing more than 200 lawsuits by cities, counties and others over the opioid epidemic recently reached out to some state attorneys general about meeting as he pushes for a quick settlement of the litigation.

Pages: 1 2 | Single Page

Filed Under: Analgesics, Drug Updates Tagged With: Delaware, lawsuit, Legal, opioid crisis, Opioids

You Might Also Like:
  • Missouri Sues Opioid Manufacturers, Joining Two other U.S. States
  • Kentucky Accuses McKesson of Helping Fuel the Opioid Epidemic
  • New Hampshire Sues Purdue Pharma over Opioid Marketing
  • Kentucky Accuses Endo of Contributing to Opioid Epidemic

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.